Envoy Medical (NASDAQ:COCH – Get Free Report) and Sanara MedTech (NASDAQ:SMTI – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, valuation, profitability and analyst recommendations.
Valuation and Earnings
This table compares Envoy Medical and Sanara MedTech’s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Envoy Medical | $320,000.00 | 316.66 | -$29.91 million | N/A | N/A |
| Sanara MedTech | $64.99 million | 4.32 | -$4.30 million | ($0.52) | -62.69 |
Sanara MedTech has higher revenue and earnings than Envoy Medical.
Volatility & Risk
Analyst Recommendations
This is a breakdown of current ratings and target prices for Envoy Medical and Sanara MedTech, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Envoy Medical | 0 | 0 | 2 | 0 | 3.00 |
| Sanara MedTech | 0 | 0 | 1 | 0 | 3.00 |
Envoy Medical currently has a consensus price target of $6.00, indicating a potential upside of 16.05%. Sanara MedTech has a consensus price target of $44.00, indicating a potential upside of 34.97%. Given Sanara MedTech’s higher probable upside, analysts plainly believe Sanara MedTech is more favorable than Envoy Medical.
Profitability
This table compares Envoy Medical and Sanara MedTech’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Envoy Medical | N/A | N/A | -100.39% |
| Sanara MedTech | -6.62% | -11.12% | -7.11% |
Institutional & Insider Ownership
8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are owned by institutional investors. 0.7% of Envoy Medical shares are owned by insiders. Comparatively, 55.2% of Sanara MedTech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Summary
Envoy Medical beats Sanara MedTech on 6 of the 11 factors compared between the two stocks.
About Envoy Medical
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
About Sanara MedTech
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.
